Longevity & Aging · Diets · Metabolic & Cardiometabolic

Mediterranean diet decreases cardiovascular disease

In plain terms: Does a Mediterranean diet lower heart attack and stroke risk?

Strong support Longevity & Aging

Part of: 🥗 mediterranean diet

RefutedContestedStrong support

consensus score 0.83

Yes — among the strongest diet evidence, mostly from fewer strokes.

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

13 support 0 contradict 0 tested null 3 mixed · 16 sources, 13 independent groups · 3 superseded — pooled inside a review, counted once

What the evidence shows

The Mediterranean diet (+olive oil/+nuts) reduced major cardiovascular events ~30% in high-risk adults - the strongest CAUSAL longevity-diet evidence, but a flawed pillar: the original trial was retracted for a randomization breach and republished (effect survived), industry-funded, benefit driven mainly by stroke.

Cochrane agrees with us see how our grade compares ▾

Cochrane · low-to-moderate: moderate-quality evidence for reduction in strokes Agrees with our grade

primary prevention, PREDIMED); low-quality evidence for reduction in total and CVD mortality; paucity of evidence for secondary prevention

“Despite the relatively large number of studies included in this review, there is still some uncertainty regarding the effects of a Mediterranean-style diet on clinical endpoints and CVD risk factors for both primary and secondary prevention. The quality of evidence for the modest benefits on CVD risk factors in primary prevention is low or moderate, with a small number of studies reporting minimal harms. There is a paucity of evidence for secondary prevention.”

Why we agree: we reached the same direction independently, from our own appraisal of 16 sources. Two methods landing in the same place is a stronger signal than either alone.

What is Cochrane, and why trust it?

Cochrane produces systematic reviews: instead of running a new study, they gather every trial ever done on a question, judge how well each was run, and pool the results. They take no commercial or industry funding, which is why the medical community treats their reviews as a gold standard — and why we check our own verdicts against theirs.

About Cochrane ↗ · Get involved / support ↗

Read the Cochrane review ↗

The evidence (19)

Source	Grade	Stance	Quality	Finding
Martínez-González MA, Bes-Rastrollo M, Sayon-Orea C, Ruiz-Canela M, Timiraos J, Toledo E, Sorlí JV, Salas-Salvado J, Gómez-Gracia E, Fiol M, Shröeder H, Lapetra J, Serra-Majem L, Pintó X, Barbería-Latasa M, Ros E, Babio N, Ortega C, de la Torre R, Lamuela-Raventos RM, Estruch R 2026 · European heart journal	RCT	mixed	moderate	PREDIMED: CVD HR 0.84 (0.61-1.15, ns) excl. wine, 0.55 (0.36-0.83) incl. wine; SUN cohort CVD assoc. ns
Karam G, Agarwal A, Sadeghirad B, Jalink M, Hitchcock CL, Ge L, Kiflen R, Ahmed W, Zea AM, Milenkovic J, Chedrawe MA, Rabassa M, El Dib R, Goldenberg JZ, Guyatt GH, Boyce E, Johnston BC 2023 · BMJ	meta-analysis	supports	high	FT BMJ network-MA all-cause mortality OR0.72 (0.56-0.92) MODERATE GRADE
Sofi F, Cesari F, Abbate R, Gensini GF, Casini A 2008 · BMJ	observational	supports	moderate	Meta-analysis: 2-point higher Mediterranean adherence associated with 9% lower CV mortality and 9% lower overall mortality.
Sebastian SA, Padda I, Johal G 2024 · Curr Probl Cardiol	meta-analysis	supports	moderate	Meta-analysis of 4 RCTs (Lyon Diet Heart, Indo-Mediterranean Diet Heart, PREDIMED, CORDIOPREV; 10,054 participants, mean age 57, 2-7 y follow-up), random effects. MedDiet vs control: MACE OR 0.52 (95% CI 0.32-0.84, p=0.008, I2 87%); MI OR 0.62 (0.41-0.92); stroke OR 0.63 (0.48-0.87, I2 0%); revascularization not significant. High heterogeneity on MACE; only four trials, one (Indo-Mediterranean) under a published integrity concern. Abstract only.
Delgado-Lista J, Alcala-Diaz JF, Torres-Peña JD, Quintana-Navarro GM, Arenas Larriva AP, Fuentes F, Garcia-Rios A, Yubero-Serrano EM, Rangel-Zuñiga OA, Camargo A, Rodriguez-Cantalejo F, Katsiki N, Perez-Martinez P, Lopez-Miranda J, CORDIOPREV Investigators 2026 · Eur J Intern Med	RCT	supports	high	CORDIOPREV RCT (n=1002, 7-yr secondary prevention): higher adherence lowered MACE (HR ~0.14 highest vs lowest) - but a low-fat diet performed comparably, so the benefit tracks adherence/diet quality, not Mediterranean-specificity.
Arenas-Montes J, Garcia-Fernandez H, Alcala-Diaz JF, Boughanem H, Allais A, Gutierrez-Mariscal FM, Arenas-de Larriva AP, Ojeda-Rodriguez A, Malagon MM, Priego-Capote F, Delgado-Lista J, Perez-Martinez P, Camargo A, Lopez-Miranda J 2026 · The American journal of clinical nutrition	RCT	mixed	moderate	CORDIOPREV secondary analysis: MACE recurrence HR 1.42 (1.01-2.00) with high postprandial LPS; MED diet lower MACE risk than LF diet only in LPS subgroup
Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pintó X, Basora J, Muñoz MA, Sorlí JV, Martínez JA, Fitó M, Gea A, Hernán MA, Martínez-González MA, PREDIMED Study Investigators 2018 · N Engl J Med	RCT	supports	high	PROVENANCE FLAG: 2013 PREDIMED retracted for randomization errors, republished 2018 corrected; effect persisted ↩ SUPERSEDED — pooled in the review above, counted once
Doundoulakis I, Farmakis IT, Theodoridis X, Konstantelos A, Christoglou M, Kotzakioulafi E, Chrysoula L, Siargkas A, Karligkiotis A, Kyprianou G, Mastromanoli E, Soulaidopoulos S, Zafeiropoulos S, Antza C, Tsiachris D, Chourdakis M 2024 · Nutr Rev	meta-analysis	supports	moderate	Network MA of dietary RCTs with hard CV outcomes: MedDiet among most effective for reducing CV events
Delgado-Lista J, Alcala-Diaz JF, Torres-Peña JD, Quintana-Navarro GM, Fuentes F, Garcia-Rios A, Ortiz-Morales AM, Gonzalez-Requero AI, Perez-Caballero AI, Yubero-Serrano EM, Rangel-Zuñiga OA, Camargo A, Rodriguez-Cantalejo F, Lopez-Segura F, Badimon L, Ordovas JM, Perez-Jimenez F, Perez-Martinez P, Lopez-Miranda J, CORDIOPREV Investigators 2022 · Lancet	RCT	supports	high	CORDIOPREV 7-yr RCT (n=1002 CHD patients): Mediterranean diet superior to low-fat for secondary prevention of major CV events. ↩ SUPERSEDED — pooled in the review above, counted once
Guasch-Ferré M, Hu FB, Martínez-González MA, Fitó M, Bulló M, Estruch R, Ros E, Corella D, Recondo J, Gómez-Gracia E, Fiol M, Lapetra J, Serra-Majem L, Muñoz MA, Pintó X, Lamuela-Raventós RM, Basora J, Buil-Cosiales P, Sorlí JV, Ruiz-Gutiérrez V, Martínez JA, Salas-Salvadó J 2014 · BMC Med	observational	supports	moderate	PREDIMED cohort analysis: higher olive oil (esp. extra-virgin) intake associated with lower CVD events and cardiovascular mortality.
Rosato V, Temple NJ, La Vecchia C, Castellan G, Tavani A, Guercio V 2019 · Eur J Nutr	meta-analysis	supports	high	SR/meta of cohorts + RCTs: high Mediterranean adherence associated with ~15-30% lower CVD incidence and CHD/stroke.
Volpe R, Ciccone MM, Pala B, Barbarano F, Camastra S, Caprio M, Casirati A, Ferrera A, Galletti F, Greatti A, Mollica MP, Paolillo S, Parretti D, Nucci D, Veronese N, Fontana L, Maggi S, Onder G, Silano M, Zanetti M, Gianfredi V, Ricci M, Volpe M, Mediterranean Diet Guideline Group 2025 · Nutrition	meta-analysis	supports	high	Meta 19 studies (>91,000): higher Mediterranean-diet adherence lowered major CV events (RCT RR 0.44; cohort RR 0.95) and mortality; effects on BP and lipids were not significant.
Becerra-Tomás N, Blanco Mejía S, Viguiliouk E, Khan T, Kendall CWC, Kahleova H, Rahelić D, Sievenpiper JL, Salas-Salvadó J 2020 · Critical reviews in food science and nutrition	meta-analysis	supports	moderate	RCT pooled: CVD incidence RR 0.62 (0.50-0.78), MI RR 0.65 (0.49-0.88); cohorts: CVD-mortality RR 0.79, stroke RR 0.80
Ungvari Z, Fekete M, Varga P, Fekete JT, Buda A, Szappanos Á, Lehoczki A, Mózes N, Grosso G, Menyhart O, Munkácsy G, Tarantini S, Yabluchanskiy A, Ungvari A, Győrffy B 2025 · GeroScience	meta-analysis	supports	moderate	[FT-verified] GeroScience MA 30 studies vs stroke; pooled HR favorable
Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC, Hu FB 2009 · Circulation	observational	supports	high	Nurses' Health Study (n~74886 women): top Mediterranean-adherence quintile had lower incident CHD, stroke and CVD mortality. ↩ SUPERSEDED — pooled in the review above, counted once
Ahmadirad H, Pasdar Y, Moludi J, Sedighi M, Moradinazar M, Teymoori F, Nachvak SM, Mirmiran P, Farhadnejad H 2026 · Nutrition & metabolism	meta-analysis	mixed	moderate	MIND diet MA (23 cohorts): CVD-mortality RR 0.78 (0.67-0.90) significant; CVD incidence RR 0.86 (0.68-1.08) NOT significant
Li Y, Stern D, Martínez-González MA, Yang S, Chavarro JE, Manson JE, Rimm EB, Platt RW, Chiu YH 2026 · The American journal of clinical nutrition	observational	supports	moderate	Target-trial emulation, NHS/HPFS: 20-y CVD (MI/revasc/stroke/CV-death) risk ratio 0.79 (0.70-0.91) high-risk; 0.90 (0.84-0.95) general pop
de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N 1999 · Circulation	RCT	supports	high	Lyon Diet Heart secondary-prevention RCT: Mediterranean-style diet cut cardiac death + nonfatal MI ~50-70% post-MI.
Golzarand M, Nikparast A, Khodayari G, Vakilbashi N, Mirmiran P, Azizi F 2026 · Nutrition & metabolism	observational	supports	moderate	Tehran Lipid & Glucose cohort, 10.6y: high MedDiet score + low UPF intake CHD HR 0.47 (0.29-0.75); high MedDiet even w/ high UPF HR 0.50 (0.31-0.83)

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.